Global 3D Cell Culture Market Size study, by Product (Scaffold-based 3D Cell Cultures, Scaffold-free 3D Cell Cultures, Microfluidics-based 3D Cell Cultures and Magnetic & Bioprinted 3D Cell Cultures), by Application (Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine), by End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, Cosmetics Industry and Others) and Regional Forecasts 2020-2027

Global 3D Cell Culture Market is valued approximately at USD 892 million in 2019 and is anticipated to grow with a healthy growth rate of more than 15.7% over the forecast period 2020-2027. A 3D cell culture is an in-vitro technique wherein the cells can grow in controlled simulated or artificially created environment, outside of a living organism. This environment has similar architecture and functioning of the native tissue. 3D cell culture technique helps biological cells to differentiate, proliferate, and migrate by interacting with their surroundings in all three dimensions. This technique has varied applications in the fields of stem cell therapies, regenerative medicine, drug screening, cancer research and cell biology. The extracellular matrix in this technique enables cell–cell communication by direct contact, by secreting cytokines and trophic factors. The growing prevalence of chronic diseases rise in demand in organ transplantation, tissue regeneration, and regenerative medicine are the few factors responsible for growth of the market over the forecast period. The rising number of organ donors due to the favourable government initiatives & growing number of deceased donors is creating a lucrative opportunity for the growth of market over the forecast years. For instance: in 1994, India government framed Transplantation of Human Organ Act to enable a proper system for removal, storage and transplantation of human organ and framed budget of approx. USD 19.95 million to promote organ donation from deceased person. Similarly, In October 1982, a federal agency, Health Resources and Services Administration (HRSA) was established in United States. The agency monitors the transplantation system of organ in the economy and provides the safest and most equitable system for allocation, transplantation, and distribution of donated organs. Thus, such factors escalate the number of organ donors across the globe, creating a lucrative thrust to the market growth. Whereas, lack of infrastructure for 3d cell-based research and high cost of cell biology research is the major factor restraining the growth of global 3D Cell Culture market during the forecast period.


The regional analysis of global 3D Cell Culture market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world owing to the increasing incidence of cancer and the presence of a well-established pharmaceutical & biotechnology industry. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:
Thermo Fisher Scientific
Corning Incorporated
Merck KGaA
Lonza Group
Reprocell
3D Biotek LLC
Emulate, Inc.
CN Bio Innovations Limited
Hamilton Company
Insphero AG


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:


by Product:
Scaffold-based 3D Cell Cultures
Scaffold-free 3D Cell Cultures
Microfluidics-based 3D Cell Cultures
Magnetic & Bioprinted 3D Cell Cultures

by Application:
Cancer & Stem Cell Research
Drug Discovery & Toxicology Testing
Tissue Engineering & Regenerative Medicine


By End-User:
Pharmaceutical & Biotechnology Companies
Research Institutes
Cosmetics Industry
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global 3D Cell Culture Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors